SCLP — Scancell Holdings Share News
0.000.00%
- £116.64m
- £123.10m
REG - Scancell Hlds - First iSCIB1+ patient dosed
AnnouncementREG - Scancell Hlds - Appointment of Sath Nirmalananthan to the Board
AnnouncementRCS - Scancell Hlds - Scancell Attendance at Upcoming Conferences
AnnouncementREG - Scancell Hlds - Presenting at Next-Gen Immuno-Oncology Conference
AnnouncementREG - Scancell Hlds - Change of Auditor
AnnouncementREG - Scancell Hlds - Directorate Change
AnnouncementREG - Scancell Hlds - Interim Results
AnnouncementREG - Scancell Hlds - Notice of Interim Results and Presentation
AnnouncementREG - Scancell Hlds - Update on SCOPE trial
AnnouncementREG - Scancell Hlds - Holding(s) in Company
AnnouncementREG - Scancell Hlds - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 20/12/2023
AnnouncementREG - Scancell Hlds - Result of the Open Offer
AnnouncementREG - Scancell Hlds - PDMR Notification
AnnouncementREG - AIM - AIM Notice - 05/12/2023
AnnouncementREG - Scancell Hlds - Results of Placing
AnnouncementREG - Scancell Hlds - Proposed Capital Raise to raise approximately £6m
AnnouncementREG - Scancell Hlds - Result of AGM
AnnouncementREG - Scancell Hlds - Update on SCOPE trial
Announcement